Unknown

Dataset Information

Combining PARP inhibition, radiation, and immunotherapy: A possible strategy to improve the treatment of cancer?


ABSTRACT: Immunotherapy has revolutionized the practice of oncology, improving survival in certain groups of patients with cancer. Immunotherapy can synergize with radiation therapy, increase locoregional control, and have abscopal effects. Combining it with other treatments, such as targeted therapies, is a promising means of improving the efficacy of immunotherapy. Because the value of immunotherapy is amplified with the expression of tumor antigens, coupling poly(ADP-ribose) polymerase (PARP) inhibitors and immunotherapy might be a promising treatment for cancer. Further, PARP inhibitors (PARPis) are being combined with radiation therapy to inhibit DNA repair functions, thus enhancing the effects of radiation; this association might interact with the antitumor immune response. Cytotoxic T lymphoc

SUBMITTER: Cesaire M 

PROVIDER: S-EPMC6321381 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature